A Pfizer and Cytel veteran on why statisticians belong at trial design, and why fewer sponsors keep them in-house.
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Token Costs Will Decide Clinical Supply AI
- A Framework For Diagnosing Clinical Research Technology Maturity
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Simplifying The Data Journey From EHR To EDC
Explore how open API architecture represents a significant advancement in the integration of EHR and EDC systems, enhancing the potential of EHR data for clinical research.
-
Enhancing Oncology Trials With Clinical Platform Solutions
This example involves a top 10 pharmaceutical company and explores how they were able to improve oncology trial efficiency, safety, patient experience, and more using a platform approach.
-
5 Benefits Of Using A Study Management Tool
See how study management tools simplify clinical trial management by centralizing all study information, enhancing efficiency and precision, and more.
-
eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs
Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.
-
How Can Sponsors Enable Research-Naïve Clinical Trial Sites
Clinical trial capacity in the U.S. is heavily concentrated, and technology is playing a critical role in enabling a shift to expanding site networks and alleviating the burden on sites and patients.
-
The Language Of eCOAs
In this article, learn more about COAs, and their electronic counterparts, eCOAs.
-
Endpoint Adjudication Best Practices: What Top Teams Do Differently
Poorly designed endpoint adjudication risks trial delays and data errors. Learn to optimize your process by aligning data capture, finalizing charters early, and using true arbitration.
-
Our Unified Platform Serves As eSource For COVID Treatment Trial
Signant Biotech optimized technology for an emerging biopharmaceutical's Phase 2 COVID treatment trial in critically ill patients, minimizing paper data risks and streamlining consent and data management across multiple sites and solutions.
-
Taking eCOA Technology Deployment Off The Critical Path
Consider this expedited review approach to facilitate the efficient evaluation of COAs and eCOAs, streamlining the pathway for successful trial execution.
-
Kicking Off A Clinical Trial The Right Way - With Seamless Digital Consent
Read this blog to learn more about how eConsent can enhance participant engagement and retention when used both onsite and remotely.
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- From 73% Noncompliant To 2.4%: Building A Compliance Office
- How AI Is Used To Predict Trial Performance Before Enrollment
- Two Planning Mistakes That Quietly Sink Clinical Programs
- A Framework For Diagnosing Clinical Research Technology Maturity
RECENT NEWSLETTERS
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps